Quantcast
Last updated on April 16, 2014 at 6:35 EDT

Latest lidocaine Stories

2009-06-25 13:15:00

SAVANNAH, Ga., June 25 /PRNewswire/ -- Jellyfish Squish(TM), an FDA compliant solution that works within minutes to relieve the pain of jellyfish stings, was recently proved to be effective on stings caused by the Portuguese man-of-war. Jellyfish Squish(TM) is produced by Coastal Solutions, Inc. in Savannah, Ga., and can be purchased online and at select stores including drug stores and beach supply stores. In May of 2009 Dr. Peter Verity, a world renowned marine biologist at the Skidaway...

2009-05-28 07:00:00

FRANKLIN, Mass., May 28 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced today that it has signed a license agreement with Ferndale Pharma Group ("Ferndale"), under which Echo granted Ferndale the right to develop, market, sell and distribute Echo's Prelude(TM) SkinPrep System ("Prelude") for painless, needle-free skin preparation prior to the application of topical 4% lidocaine cream for fast-acting, local dermal anesthesia prior to a wide-range of...

df5e1b62d25148f04c09636cd36c563f1
2009-04-15 07:09:12

Breast-feeding an infant offers yet another advantage, according to new research conducted by Turkish investigators that suggests pain connected with vaccination is considerably lessened for infants nurtured on mother's milk, Reuters reported on Tuesday. "Even young children have a pain memory, causing them to anticipate painful procedures and react more intensely if they have undergone previous painful procedures with inadequate analgesia," the researchers write in the Journal of...

2009-04-07 14:55:27

Men with premature ejaculation who used a topical spray before intercourse were able to delay orgasm six times longer than normal, Irish researchers said. Lead researcher W. Wallace Dinsmore of the Royal Victoria Hospital, Belfast, Northern Ireland, said the study involved 300 men with clinically diagnosed lifelong premature ejaculation from 31 centers in Britain, Czech Republic, Hungary and Poland. The men were randomized into two groups -- 200 used the PSD502 spray, which contains 7.5mg...

2009-03-31 06:00:00

ASHBURN, Va., March 31 /PRNewswire/ --- Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has filed a US 510k application for its CollaRx(TM) Lidocaine Sponge for the management of painful wounds. It is estimated that each year 13 million patients worldwide suffer from chronic wounds (venous stasis ulcers, pressure ulcers, diabetic foot ulcers, etc.) 35 percent of all chronic wounds do not heal within 5 years. Patients suffering from wound pain have...

2009-01-16 16:51:21

The U.S. Food and Drug Administration is warning of potentially life-threatening side effects of skin numbing products. The products, known as topical anesthetics contain lidocaine, tetracaine, benzocaine and prilocaine in a cream, ointment or gel. The FDA is concerned the anesthetic drugs, if used improperly, may cause life-threatening side effects, such as irregular heartbeat, seizures, breathing difficulties, coma or even death. The agency said two women died using topical anesthetics...

2008-12-08 08:33:00

Trial Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical Anaesthetic Xylocaine(R) MELBOURNE, Australia, Dec. 8 /PRNewswire-FirstCall/ --Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of a phase 1 clinical trial that examined the ability of its patented drug delivery system, TPM, to topically deliver the pain relief drug, lidocaine, safely into humans. The trial demonstrated that the patented lidocaine...

2008-10-16 12:00:25

Akorn, a provider of sterile specialty pharmaceuticals, has commercially launched Akten gel 3.5%, a topical ocular anesthetic ophthalmic drug product. According to the company, Akten represents the first FDA approved drug product indicated for use as an ocular anesthetic in four decades. Akten is the only approved ocular gel formulation that also contains the highest concentration of lidocaine. Akten can also be used as a local anesthetic indicated for ocular surface anesthesia during...

2008-10-15 09:00:48

Akorn, Inc. (NASDAQ: AKRX) today announced the commercial launch of Akten(TM) Gel 3.5%, a topical ocular anesthetic ophthalmic drug product. Akten(TM) represents the first FDA approved drug product indicated for use as an ocular anesthetic in four decades. Akten(TM) is the only approved ocular gel formulation that also contains the highest concentration of lidocaine. Akten(TM) has several unique features: it is preservative free, non toxic to the cornea, does not sting due to its...

2008-10-10 09:00:52

Akorn, a provider of sterile specialty pharmaceuticals, has received the FDA approval of NDA 22-221 for Akten ophthalmic gel 3.5%, a topical, ocular anesthetic formulation. The new drug application (NDA) was filed on June 29, 2007 following the results from a randomized, placebo controlled, Phase III clinical trial in 209 subjects who met the primary endpoint in all three dosing arms (p Akten is a novel, unit dose, preservative free lidocaine gel product, stored at room temperature and...